Wolfgang Miesbach: New Editorial Highlights – 6 Year Outcomes of Hemophilia B Gene Therapy
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn about a recent article he and his colleague co-authored, published in Blood Advances, adding:
“Happy to share that our editorial is now online in Blood Advances.
We discuss the 6‑year follow‑up of a phase 1/2 study in 14 adults with severe or moderately severe haemophilia B who received a single IV infusion of fidanacogene elaparvovec (5 × 10¹¹ vg/kg), reporting durable FIX levels in the mild range at year 6, sustained bleed reduction, and clinically meaningful improvements in patient‑reported quality of life.
We also highlight safety and methodological nuances, including ALT elevations in 8/14 participants during years 2–6, hepatic steatosis in those with elevated baseline BMI, interindividual variability in FIX expression, and the implications of Pfizer’s withdrawal of Beqvez despite these encouraging long‑term outcomes.
Many thanks to my co‑author Roland W Herzog for this excellent collaboration.”
Title: Six-year FIX-padua gene therapy in hemophilia B
Authors: Wolfgang Miesbach, Roland Herzog
Other posts featuring Wolfgang Miesbach on Hemostasis Today.
-
May 18, 2026, 13:10Ritika Jankar: Hemophilia Market Size to Reach USD 23.46 Billion by 2035
-
May 18, 2026, 13:10Natasha Kazi: Early Anticoagulation Linked to Better Outcomes in Acute PE
-
May 18, 2026, 13:02Paris Margaritis: Native Cellular Biology and the Future of Durable Hemophilia A Gene Therapy
-
May 18, 2026, 12:48Ilenia Calcaterra: Impact of Pain on Severe Haemophilia A Patients Receiving Emicizumab Prophylaxis
-
May 18, 2026, 08:12Perioperative Anticoagulation Management Isn’t a Checklist – Thrombosis Canada
-
May 18, 2026, 08:04Sophia Delicou: Iron Chelation Plateaus and Organ-Specific Iron Distribution in β-Thalassemia
-
May 18, 2026, 08:04Comprehensive Analysis of Patients With Prior Negative Genetic Testing for Wilson Disease – JHEP Reports
-
May 18, 2026, 08:022026 ITP Annual Patients’ Convention – ITP Support Association
-
May 18, 2026, 08:02Thomas Rocco Jr.: World Hypertension Day and the Future of Cardiovascular Prevention